Agios Pharmaceuticals, Inc. (AGIO)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Agios Pharmaceuticals, Inc. (AGIO)
Go deeper and ask any question about AGIO
Company Performance
Current Price
as of Oct 03, 2024$40.56
P/E Ratio
N/A
Market Cap
$2.31B
Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAGIO
- Price$40.56-2.94%
Trading Information
- Market Cap$2.31B
- Float96.94%
- Average Daily Volume (1m)583,573
- Average Daily Volume (3m)518,173
- EPS-$6.49
Company
- Revenue$31.31M
- Rev Growth (1yr)28.35%
- Net Income-$96.12M
- Gross Margin64.16%
- EBITDA Margin-1,209.80%
- EBITDA-$104.22M
- EV$1.94B
- EV/Revenue62.10
- P/EN/A
- P/S73.59
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset